Compass Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 850K |
| Cost of Goods Sold | 368K | 370K | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | -368K | -370K | 0 | 0 | 0 | 0 | 0 | 850K |
| R&D Expenses | 13.4M | 13.7M | 12.8M | 16.4M | 13.1M | 13.0M | 8.6M | 11.2M |
| Operating Expenses | 19.9M | 17.6M | 15.8M | 21.1M | 18.0M | 16.6M | 12.2M | 15.9M |
| Operating Income | -20.3M | -18.0M | -15.8M | -21.1M | -18.0M | -16.6M | -12.2M | -15.0M |
| Other Income / Gains | 2.0M | 2.3M | 1.6M | 1.2M | 1.3M | 1.5M | 1.8M | 2.0M |
| Net Income | -18.3M | -15.7M | -14.3M | -19.9M | -16.6M | -15.0M | -10.5M | -13.1M |
| EPS (Diluted) | -0.10 | -0.085 | -0.10 | -0.14 | -0.12 | -0.11 | -0.076 | -0.095 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.00 |
| General And Administrative Expenses | 6.9M | 4.3M | 3.0M | 4.7M | 4.9M | 3.5M | 3.6M | 4.7M |
| Selling And Marketing Expenses | -353K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 6.6M | 4.3M | 3.0M | 4.7M | 4.9M | 3.5M | 3.6M | 4.7M |
| Other Expenses | 0 | -370K | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 20.3M | 18.0M | 15.8M | 21.1M | 18.0M | 16.6M | 12.2M | 15.9M |
| Interest Income | 2.0M | 2.3M | 1.6M | 1.2M | 1.3M | 1.6M | 1.8M | 2.0M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 368K | 370K | 19K | 367K | 364K | 359K | 465K | 466K |
| Ebitda | -17.9M | -15.3M | -14.2M | -19.5M | -16.3M | -14.7M | -10.0M | -12.6M |
| Ebitdaratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -14.835 |
| Operating Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -17.70 |
| Income Before Tax | -18.3M | -15.7M | -14.3M | -19.9M | -16.6M | -15.0M | -10.5M | -13.1M |
| Income Before Tax Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -15.384 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -15.384 |
| Epsdiluted | -0.10 | -0.085 | -0.10 | -0.14 | -0.12 | -0.11 | -0.076 | -0.095 |
| Weighted Average Shs Out | 186.4M | 184.8M | 138.3M | 138.3M | 138.2M | 136.6M | 137.6M | 137.6M |
| Weighted Average Shs Out Dil | 186.4M | 184.8M | 138.3M | 138.3M | 138.2M | 136.6M | 137.6M | 137.6M |